Peripheral Transcutaneous Neuromodulation of the Post-tibial Nerve for Solifenacin 10 mg. Hyperactive Bladder Syndrome
Clinical trial NCT03468465 · UNKNOWN
Trial details
- NCT number
- NCT03468465
- Sponsor
- Fundacion para la Formacion e Investigacion Sanitarias de la Region de Murcia
- Status
- UNKNOWN
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2018-05-04
- Primary completion
- 2019-03-01
- Enrollment
- 110
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.